Pineoblastoma: Clinical Trials

2 trials for Pineoblastoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Recruiting 2

Follow Pineoblastoma: new trials by email Literature Review of Pineoblastoma trials Research Report on Pineoblastoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
SGT-53, hypofractionated radiotherapy with immunotherapy, Nivolumab - CNS Malignancies, Medulloblastoma Recurrent
Early Phase 1RecruitingChildren's National Research Institute182025-12-162026-04-29
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
Cytarabine IT, hydrocortisone, Cisplatin - CNS Embryonal Tumor, CNS, Medulloblastoma
Early Phase 1RecruitingC17 Council152025-09-232026-07-14

Narrower conditions

Pinealoma (2)  ·  Central Nervous System Neoplasms (1)  ·  Medulloblastoma (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neuroblastoma (1)  ·  Neuroectodermal Tumors, Primitive (1)  ·  Pyloric Stenosis, Hypertrophic (1)  ·  Rhabdoid Tumor (1)

Broader conditions

Brain Diseases (2)  ·  Brain Neoplasms (2)  ·  Central Nervous System Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neoplasms, Neuroepithelial (2)  ·  Nervous System Diseases (2)  ·  Nervous System Neoplasms (2)  ·  Neuroectodermal Tumors (2)  ·  Central Nervous System Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Gastric Outlet Obstruction (1)

Interventions

Carboplatin (1)  ·  Celecoxib (1)  ·  Cisplatin (1)  ·  Cyclophosphamide (1)  ·  Etoposide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Hydrocortisone (1)  ·  Immunotherapy (1)  ·  Isotretinoin (1)  ·  Mesna (1)  ·  Nivolumab (1)  ·  Tamoxifen (1)  ·  Temozolomide (1)  ·  Thiotepa (1)

Sponsors

C17 Council (1)  ·  Children's National Research Institute (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Annie Huang (1)  ·  Lucie Lafay-Cousin (1)  ·  Sylvia Cheng (1)